Paratek Pharmaceuticals Completes Combination with Radius Health

B-FLEXION Life Sciences to Acquire Remaining 57% of Radius Health from Patient Square and Webster Equity Partners

January 12, 2026

Pharmaceuticals

B-FLEXION Life Sciences has agreed to purchase the remaining 57% interest in Radius Health held by affiliates of Patient Square Capital and Webster Equity Partners. Radius, a specialty biopharmaceutical focused on bone health, had been taken private by B-FLEXION and Patient Square in August 2022. The transaction is expected to close by the end of Q1 2026.

Elevance Health Acquires Paragon Healthcare

March 11, 2024

Healthcare Services

Elevance Health closed its acquisition of Paragon Healthcare, an infusion services and injectable therapy provider. Following the deal, Paragon Healthcare will operate as part of CarelonRx, Elevance’s pharmacy services segment, with plans to expand geographically and scale multi-site infusion services and specialty pharmacy capabilities.

Syros Pharmaceuticals Acquires Tyme Technologies in $130M PIPE and Closes Merger

September 16, 2022

Biotechnology

Syros Pharmaceuticals (NASDAQ: SYRS) closed its merger with Tyme Technologies, acquiring TYME’s pipeline assets and net cash at closing. The transaction included a concurrent oversubscribed $130 million private investment in public equity (PIPE), and the combined company trades on Nasdaq under the SYRS ticker.

Gurnet Point Capital and Patient Square Capital Acquire Radius Health

June 23, 2022

Healthcare Services

Gurnet Point Capital and Patient Square Capital entered into a definitive agreement to acquire Radius Health in a transaction valued at approximately $890 million, including the assumption of debt. The offer is $10.00 per share in cash plus a $1.00 per share contingent value right (CVR) tied to TYMLOS (abaloparatide) net sales reaching $300 million during a 12-month period prior to December 31, 2025.

Parata Systems Acquires Synergy Medical

July 6, 2021

Medical Devices

Parata Systems, a portfolio company of Frazier Healthcare Partners, has acquired Synergy Medical, a Longueuil, Quebec-based developer of pharmacy blister-card automation technologies. The deal expands Parata’s pharmacy automation capabilities—adding Synergy’s blister automation systems and roughly 150 employees—to broaden offerings for retail, hospital, long-term care and direct-to-home pharmacies.

Paragon 28 Acquires Assets of Additive Orthopaedics

June 1, 2021

Medical Devices

Paragon 28, Inc. acquired the product lines and related assets of Additive Orthopaedics, including the FDA‑cleared 3D‑printed patient‑specific talus spacer and an integrated cloud‑based pre‑operative surgical planning application. The acquisition expands Paragon 28’s foot‑and‑ankle product offering and accelerates its strategy to integrate smart tools, AI and advanced technologies to improve patient outcomes.